Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole
作者： P.E. Goss , J.N. Ingle , S. Martino , N.J. Robert , H.B. Muss
关键词: Gynecology 、 Adjuvant therapy 、 Placebo 、 Adjuvant 、 Tamoxifen 、 Internal medicine 、 Letrozole 、 Breast cancer 、 Randomized controlled trial 、 Medicine 、 Menopause 、 Oncology
摘要: Background MA17 showed improved outcomes in postmenopausal women given extended letrozole (LET) after completing 5 years of adjuvant tamoxifen.
ed.ac.uk
elsevier.com
oup.com
paperity.org参考文章(21)
Early Breast Cancer Trialists' Collaborative Group, None, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials The Lancet. ,vol. 365, pp. 1687- 1717 ,(2005) , 10.1016/S0140-6736(05)66544-0
Mitch Dowsett, Jack Cuzick, Jim Ingle, Alan Coates, John Forbes, Judith Bliss, Marc Buyse, Michael Baum, Aman Buzdar, Marco Colleoni, Charles Coombes, Claire Snowdon, Michael Gnant, Raimund Jakesz, Manfred Kaufmann, Francesco Boccardo, Jon Godwin, Christina Davies, Richard Peto, Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen Journal of Clinical Oncology. ,vol. 28, pp. 509- 518 ,(2010) , 10.1200/JCO.2009.23.1274
Paul Goss, Leonie von Eichel, Summary of aromatase inhibitor trials: The past and future The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 106, pp. 40- 48 ,(2007) , 10.1016/J.JSBMB.2007.05.023
Sandra M Swain, Jong-Hyeon Jeong, Charles E Geyer Jr, Joseph P Costantino, Eduardo R Pajon, Louis Fehrenbacher, James N Atkins, Jonathan Polikoff, Victor G Vogel, John K Erban, Priya Rastogi, Robert B Livingston, Edith A Perez, Eleftherios P Mamounas, Stephanie R Land, Patricia A Ganz, Norman Wolmark, None, Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer The New England Journal of Medicine. ,vol. 362, pp. 2053- 2065 ,(2010) , 10.1056/NEJMOA0909638
Shannon Puhalla, Adam Brufsky, Nancy Davidson, Adjuvant endocrine therapy for premenopausal women with breast cancer. The Breast. ,vol. 18, ,(2009) , 10.1016/S0960-9776(09)70286-3
HJ Stewart, , AP Forrest, D Everington, CC McDonald, JA Dewar, RA Hawkins, RJ Prescott, WD George, Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group. British Journal of Cancer. ,vol. 74, pp. 297- 299 ,(1996) , 10.1038/BJC.1996.356
Paul E. Goss, James N. Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine J. Piccart, Monica Castiglione, Dongsheng Tu, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, Patrick Therasse, Michael J. Palmer, Joseph L. Pater, A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer New England Journal of Medicine. ,vol. 349, pp. 1793- 1802 ,(2003) , 10.1056/NEJMOA032312
J.N. Ingle, D. Tu, J.L. Pater, H.B. Muss, S. Martino, N.J. Robert, M.J. Piccart, M. Castiglione, L.E. Shepherd, K.I. Pritchard, R.B. Livingston, N.E. Davidson, L. Norton, E.A. Perez, J.S. Abrams, D.A. Cameron, M.J. Palmer, P.E. Goss, Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17 Annals of Oncology. ,vol. 19, pp. 877- 882 ,(2008) , 10.1093/ANNONC/MDM566
Harold J Burstein, Jennifer J Griggs, Ann A Prestrud, Sarah Temin, None, American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer Journal of Clinical Oncology. ,vol. 28, pp. 3784- 3796 ,(2010) , 10.1200/JCO.2009.26.3756
Paul E. Goss, James N. Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine J. Piccart, Monica Castiglione, Dongsheng Tu, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David A. Cameron, Michael J. Palmer, Joseph L. Pater, Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 Journal of the National Cancer Institute. ,vol. 97, pp. 1262- 1271 ,(2005) , 10.1093/JNCI/DJI250